AREVF OTC
AREV Life Sciences Global Corp
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -95.0%
3Y: -99.7%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$49K
-80.7% ▼
Gross Profit
$29K
-84.3% ▼
Operating Income
-$1M
+7.2% ▲
Net Income
-$1M
-45.8% ▼
EPS (Diluted)
$-0.05
+4.0% ▲
EBITDA
-$1M
-64.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $195K | $191K | $255K | $49K |
| YoY Growth | +0.0% | +0.0% | -2.1% | +33.8% | -80.7% |
| Cost of Revenue | $52K | $66K | $0 | $70K | $20K |
| Gross Profit | -$52K | $129K | $191K | $185K | $29K |
| Gross Margin | — | 66.3% | 100.0% | 72.6% | 59.3% |
| R&D Expenses | $195K | $1M | $128K | $148K | $84K |
| SG&A Expenses | $2M | $2M | $567K | $2M | $1M |
| Operating Expenses | $2M | $3M | $643K | $2M | $1M |
| Operating Income | -$2M | -$3M | -$452K | -$1M | -$1M |
| Operating Margin | — | -1554.4% | -237.3% | -587.0% | -2827.7% |
| Interest Expense | $40K | $73K | $59K | $46K | $6K |
| Income Before Tax | -$8M | -$3M | -$1M | -$990K | -$1M |
| Tax Expense | $40K | $0 | $0 | $0 | $0 |
| Net Income | -$8M | -$3M | -$1M | -$990K | -$1M |
| Net Margin | — | -1640.0% | -550.4% | -388.4% | -2940.4% |
| EPS (Diluted) | $-1.47 | $-0.36 | $-0.07 | $-0.05 | $-0.05 |
| EBITDA | -$2M | -$3M | -$500K | -$798K | -$1M |
| Shares Outstanding | 6M | 9M | 15M | 27M | 30M |